Gerry is a Consultant Clinical Oncologist at the Cancer Centre, Belfast City Hospital, where his areas of expertise are the treatment of lung and breast cancer with both systemic and radiation therapy. He is a Senior Lecturer at Queen’s University Belfast, carrying out a range of research projects related to improving the effectiveness of radiotherapy in breast and lung cancer. Gerry is the Chief Investigator for the International Atomic Agency funded PERTAIN study into the use of PET/CT scanning in aiding lung cancer radiotherapy in low and middle income countries, and he is Co-Chief Investigator of the UK’s CONCORDE study of novel anti-cancer drugs with radiotherapy in the treatment of lung cancer. He is also Chief Investigator of the SINCERE study into skin care for patients receiving radiotherapy. Gerry is a Consultant Clinical Oncologist at the Cancer Centre, Belfast City Hospital, where his areas of expertise are the treatment of lung and breast cancer with both systemic and radiation therapy. He is a Senior Lecturer at Queen’s University Belfast, carrying out a range of research projects related to improving the effectiveness of radiotherapy in breast and lung cancer. Gerry is the Chief Investigator for the International Atomic Agency funded PERTAIN study into the use of PET/CT scanning in aiding lung cancer radiotherapy in low and middle income countries, and he is Co-Chief Investigator of the UK’s CONCORDE study of novel anti-cancer drugs with radiotherapy in the treatment of lung cancer. He is also Chief Investigator of the SINCERE study into skin care for patients receiving radiotherapy.

Cancer